Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy

Biomaterials

Volumn 31, Issue 30, 2010, Pages 7813-7826

  Un, Keita ^a,b   Kawakami, Shigeru ^a   Suzuki, Ryo ^c   Maruyama, Kazuo ^c   Yamashita, Fumiyoshi ^a   Hashida, Mitsuru ^a,d  

^a KYOTO UNIVERSITY   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Antigen presenting cells; Bubble lipoplexes; DNA vaccine therapy; Gene transfer; Mannose receptors; Ultrasound exposure

Indexed keywords

ANTIGEN PRESENTING CELLS; DNA VACCINE THERAPY; LIPOPLEXES; MANNOSE RECEPTORS; ULTRASOUND EXPOSURE;

ANTIGENS; CELLS; CYTOLOGY; DNA; GENE EXPRESSION; GENE TRANSFER; NUCLEIC ACIDS; ULTRASONICS; VACCINES;

GENE THERAPY;

DNA VACCINE; LIPOFECTAMINE; LIPOPLEX; MACROGOL 2000; MANNOSE; MANNOSE MACROGOL 2000 LIPOPLEX CONJUGATE; MANNOSE RECEPTOR; NUCLEIC ACID; OVALBUMIN; PLASMID DNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; CYTOPLASM; ENDOCYTOSIS; EXPOSURE; FEMALE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL GENE DELIVERY SYSTEM; LYMPHOMA; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; TARGET CELL; ULTRASOUND;

ANIMALS; ANTIGEN PRESENTATION; CELL LINE; CYTOKINES; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, MHC CLASS I; HUMANS; LIPOSOMES; LIVER; MANNOSE; MATERIALS TESTING; MICE; MICE, INBRED C57BL; MOLECULAR STRUCTURE; POLYETHYLENE GLYCOLS; TRANSFECTION; ULTRASONICS; VACCINES, DNA;

EID: 77955772869     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.06.058     Document Type: Article

References (49)

1. Kawakami S., Sato A., Nishikawa M., Yamashita F., Hashida M. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther 2000, 7:292-299.
2. Schiffelers R.M., Koning G.A., ten Hagen T.L., Fens M.H., Schraa A.J., Janssen A.P., et al. Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. J Control Release 2003, 91:115-122.
3. Torchilin V.P., Levchenko T.S., Rammohan R., Volodina N., Papahadjopoulos-Sternberg B., D'Souza G.G. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc Natl Acad Sci U S A 2003, 100:1972-1977.
4. Kirpotin D.B., Drummond D.C., Shao Y., Shalaby M.R., Hong K., Nielsen U.B., et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res 2006, 66:6732-6740.
5. Goldstein D., Gofrit O., Nyska A., Benita S. Anti-HER2 cationic immunoemulsion as a potential targeted drug delivery system for the treatment of prostate cancer. Cancer Res 2007, 67:269-275.
6. Oba M., Aoyagi K., Miyata K., Matsumoto Y., Itaka K., Nishiyama N., et al. Polyplex micelles with cyclic RGD peptide ligands and disulfide cross-links directing to the enhanced transfection via controlled intracellular trafficking. Mol Pharmacol 2008, 5:1080-1092.
7. Sheng K.C., Kalkanidis M., Pouniotis D.S., Esparon S., Tang C.K., Apostolopoulos V., et al. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo. Eur J Immunol 2008, 38:424-436.
8. Satkauskas S., Bureau M.F., Puc M., Mahfoudi A., Scherman D., Miklavcic D., et al. Mechanisms of in vivo DNA electrotransfer: respective contributions of cell electropermeabilization and DNA electrophoresis. Mol Ther 2002, 5:133-140.
9. Mukai H., Kawakami S., Kamiya Y., Ma F., Takahashi H., Satake K., et al. Pressure-mediated transfection of murine spleen and liver. Hum Gene Ther 2009, 20:1157-1167.
10. Nishikawa M., Nakayama A., Takahashi Y., Fukuhara Y., Takakura Y. Reactivation of silenced transgene expression in mouse liver by rapid, large-volume injection of isotonic solution. Hum Gene Ther 2008, 19:1009-1020.
11. Hernot S., Klibanov A.L. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 2008, 60:1153-1166.
12. Suzuki R., Takizawa T., Negishi Y., Utoguchi N., Sawamura K., Tanaka K., et al. Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles. J Control Release 2008, 125:137-144.
13. Negishi Y., Endo Y., Fukuyama T., Suzuki R., Takizawa T., Omata D., et al. Delivery of siRNA into the cytoplasm by liposomal bubbles and ultrasound. J Control Release 2008, 132:124-130.
14. Lentacker I., Geers B., Demeester J., De Smedt S.C., Sanders N.N. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. Mol Ther 2010, 18:101-108.
15. Liu Y., Miyoshi H., Nakamura M. Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. J Control Release 2006, 114:89-99.
16. Un K., Kawakami S., Suzuki R., Maruyama K., Yamashita F., Hashida M. Enhanced transfection efficiency into macrophages and dendritic cells by the combination method using mannosylated lipoplexes and bubble liposomes with ultrasound exposure. Hum Gene Ther 2010, 21:65-74.
17. Kawabata K., Takakura Y., Hashida M. The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake. Pharm Res 1995, 12:825-830.
18. Potter N.S., Harding C.V. Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes. J Immunol 2001, 167:2538-2546.
19. Hattori Y., Suzuki S., Kawakami S., Yamashita F., Hashida M. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route. J Control Release 2005, 108:484-495.
20. Hattori Y., Kawakami S., Lu Y., Nakamura K., Yamashita F., Hashida M. Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration. J Gene Med 2006, 8:824-834.
21. Lee Y.C. 2-Imino-2-methoxyethyl 1-thioglycosides: new reagents for attaching sugars to proteins. Biochemistry 1976, 15:3956-3963.
22. Wang L.H., Rothberg K.G., Anderson R.G. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 1993, 123:1107-1117.
23. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987, 262:5592-5595.
24. West M.A., Bretscher M.S., Watts C. Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells. J Cell Biol 1989, 109:2731-2739.
25. Hattori Y., Kawakami S., Nakamura K., Yamashita F., Hashida M. Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route. J Pharmacol Exp Ther 2006, 318:828-834.
26. Rigby P.W.J., Dieckmann M., Rhodes C., Berg P. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol 1977, 113:237-251.
27. Kawakami S., Wong J., Sato A., Hattori Y., Yamashita F., Hashida M. Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice. Biochim Biophys Acta 2000, 1524:258-265.
28. Taylor P.R., Gordon S., Martinez-Pomares L. The mannose receptor: linking homeostasis and immunity through sugar recognition. Trends Immunol 2005, 26:104-110.
29. Tacken P.J., de Vries I.J., Torensma R., Figdor C.G. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol 2007, 7:790-802.
30. Kurts C. CD11c: not merely a murine DC marker, but also a useful vaccination target. Eur J Immunol 2008, 38:2072-2075.
31. Steinman R.M., Banchereau J. Taking dendritic cells into medicine. Nature 2007, 449:419-426.
32. Hume D.A. Macrophages as APC and the dendritic cell myth. J Immunol 2008, 181:5829-5835.
33. Liu K., Waskow C., Liu X., Yao K., Hoh J., Nussenzweig M. Origin of dendritic cells in peripheral lymphoid organs of mice. Nat Immunol 2007, 8:578-583.
34. Abe Y., Kuroda Y., Kuboki N., Matsushita M., Yokoyama N., Kojima N. Contribution of complement component C3 and complement receptor type 3 to carbohydrate-dependent uptake of oligomannose-coated liposomes by peritoneal macrophages. J Biochem 2008, 144:563-570.
35. Sakurai F., Inoue R., Nishino Y., Okuda A., Matsumoto O., Taga T., et al. Effect of DNA/liposome mixing ratio on the physicochemical characteristics, cellular uptake and intracellular trafficking of plasmid DNA/cationic liposome complexes and subsequent gene expression. J Control Release 2000, 66:255-269.
36. Song L.Y., Ahkong Q.F., Rong Q., Wang Z., Ansell S., Hope M.J., et al. Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. Biochim Biophys Acta 2002, 1558:1-13.
37. Deshpande M.C., Davies M.C., Garnett M.C., Williams P.M., Armitage D., Bailey L., et al. The effect of poly(ethylene glycol) molecular architecture on cellular interaction and uptake of DNA complexes. J Control Release 2004, 97:143-156.
38. Tachibana K., Uchida T., Ogawa K., Yamashita N., Tamura K. Induction of cell-membrane porosity by ultrasound. Lancet 1999, 353:1409.
39. Ishida O., Maruyama K., Sasaki K., Iwatsuru M. Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int J Pharm 1999, 190:49-56.
40. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K.A., Monks B.G., Knetter C.F., et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004, 5:190-198.
41. Leifer C.A., Brooks J.C., Hoelzer K., Lopez J., Kennedy M.N., Mazzoni A., et al. Cytoplasmic targeting motifs control localization of toll-like receptor 9. J Biol Chem 2006, 281:35585-35592.
42. Tousignant J.D., Gates A.L., Ingram L.A., Johnson C.L., Nietupski J.B., Cheng S.H., et al. Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid: plasmid DNA complexes in mice. Hum Gene Ther 2000, 11:2493-2513.
43. Meyer O., Schughart K., Pavirani A., Kolbe H.V. Multiple systemic expression of human interferon-beta in mice can be achieved upon repeated administration of optimized pcTG90-lipoplex. Gene Ther 2000, 7:1606-1611.
44. Donnelly J.J., Wahren B., Liu M.A. DNA vaccines: progress and challenges. J Immunol 2005, 175:633-639.
45. Rice J., Ottensmeier C.H., Stevenson F.K. DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer 2008, 8:108-120.
46. Cook-Mills J.M., Deem T.L. Active participation of endothelial cells in inflammation. J Leukoc Biol 2005, 77:487-495.
47. Kolios G., Valatas V., Kouroumalis E. Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol 2006, 12:7413-7420.
48. Higuchi Y., Kawakami S., Yamashita F., Hashida M. The potential role of fucosylated cationic liposome/NFkappaB decoy complexes in the treatment of cytokine-related liver disease. Biomaterials 2007, 28:532-539.
49. Wong J., Kubes P., Zhang Y., Li Y., Urbanski S.J., Bennett C.F., et al. Role of ICAM-1 in chronic hepatic allograft rejection in the rat. Am J Physiol Gastrointest Liver Physiol 2002, 283:196-203.